This Article Full Text Full Text (PDF) All Versions of this Article: 43/5/1110    most recent 01.HYP.0000123075.48420.e8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rochon, G. Articles by Menu, P. Search for Related Content PubMed PubMed Citation Articles by Rochon, G. Articles by Menu, P. Pubmed/NCBI databases Substance via MeSH Related Collections Other hypertension Other Research

(Hypertension. 2004;43:1110.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Hemodilution With Stoma-Free Hemoglobin at Physiologically Maintained Viscosity Delays the Onset of Vasoconstriction

Géraldine Rochon; Alexis Caron; Marie Toussaint-Hacquard; Abdu I. Alayash; Monique Gentils; Pierre Labrude; Jean François Stoltz; Patrick Menu

From the Department of Hematology and Physiology (G.R., A.C., M.T.-H., P.L., P.M), School of Pharmacy, University Henri Poincaré-Nancy, France; Laboratory of Biochemistry and Vascular Biology (A.I.A.), Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Md; and Laboratory of Mechanical Engineering of Cells and Tissue (M.G., J.F.S.), Faculty of Medicine, Nancy, France.

Correspondence to Patrick Menu, Laboratoire d’Hématologie et de Physiologie, Faculté de Pharmacie, 5 rue Albert Lebrun, 54001 Nancy cedex, France. E-mail menu{at}pharma.uhp-nancy.fr

Solutions of modified cell-free hemoglobin, prepared from outdated red blood cells, have been developed during the past decade to circumvent the increasing need for allogeneic blood. Despite improvements in the safety and efficacy of these solutions, undesirable effects such as an increase in vascular tone leading to hypertension have not been fully resolved, which might hinder their clinical usefulness. To discriminate between the pharmacological and rheological effects of cell-free hemoglobin, we compared the effects of blood/cell-free hemoglobin mixtures of high versus low viscosity on hemodynamics and vascular hindrance, an index of vascular tone, which was normalized for blood viscosity. Anesthetized rats were subjected to 50% exchange transfusion with (1) high-viscosity solutions: whole blood (n=5) or red blood cells mixed with cell-free hemoglobin (Hb-Hv group, n=5); (2) low-viscosity solutions: cell-free hemoglobin (Hb-Lv group, n=5) or human albumin (n=5). Two hours after hemodilution, vascular hindrance remained unchanged in animals transfused with whole blood and albumin. Hb-Lv induced an immediate and sustained increase in vascular hindrance (208%). Conversely, in Hb-Hv animals, the vascular hindrance increase was delayed and smaller (27% to 147%), whereas peripheral resistance increased gradually (94% after 2 hours). Our results demonstrate the beneficial effects of cell-free hemoglobin in the presence of the animals’ own red blood cells in maintaining physiological viscosity and limiting vasoconstriction because of the pharmacological properties of cell-free hemoglobin.

Key Words: hemoglobin • vascular resistance • viscosity

This article has been cited by other articles:

				H. Sakai, A. Sato, K. Masuda, S. Takeoka, and E. Tsuchida Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier J. Biol. Chem., January 18, 2008; 283(3): 1508 - 1517. [Abstract] [Full Text] [PDF]

				P. Cabrales, A. G. Tsai, and M. Intaglietta Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1708 - H1716. [Abstract] [Full Text] [PDF]